Murali Srivathsa is the founder of Akura Medical. Akura Medical has raised $115M in total funding. Latest round: Series B. Backed by Shifamed.
Murali Srivathsa is the President and CEO of Akura Medical, a clinical-stage medical device company focused on reshaping venous thromboembolism (VTE) care. He has successfully led the company through significant funding rounds, including a $27 million seed-to-Series A and a $35 million Series B in 2023.
Full founder directory · Investor directory · Company funding database · Fundraising library